Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Getting to reproducible antibodies: the rationale for sequenced recombinant characterized reagents.

Literature DB >> 26446960

Getting to reproducible antibodies: the rationale for sequenced recombinant characterized reagents.

Andrew R M Bradbury¹, Andreas Plückthun².

Abstract

Mesh：

Substances：

Year: 2015 PMID： 26446960 DOI： 10.1093/protein/gzv051

Source DB: PubMed Journal: Protein Eng Des Sel ISSN： 1741-0126 Impact factor: 1.650

Keyword Cloud
Cited

× No keyword cloud information.

25 in total

1. Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.

Authors: Matthias Pauthner; Jenny Yeung; Chris Ullman; Joost Bakker; Thierry Wurch; Janice M Reichert; Fridtjof Lund-Johansen; Andrew R M Bradbury; Paul J Carter; Joost P M Melis
Journal: MAbs Date: 2016 Impact factor: 5.857

2. Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility.

Authors: Haiyong Peng; Thomas Nerreter; Jing Chang; Junpeng Qi; Xiuling Li; Pabalu Karunadharma; Gustavo J Martinez; Mohammad Fallahi; Jo Soden; Jim Freeth; Roger R Beerli; Ulf Grawunder; Michael Hudecek; Christoph Rader
Journal: J Mol Biol Date: 2017-08-14 Impact factor: 5.469

3. Construction, characterization and crystal structure of a fluorescent single-chain Fv chimera.

Authors: Nileena Velappan; Devin Close; Li-Wei Hung; Leslie Naranjo; Colin Hemez; Natasha DeVore; Donna K McCullough; Antonietta M Lillo; Geoffrey S Waldo; Andrew R M Bradbury
Journal: Protein Eng Des Sel Date: 2021-02-15 Impact factor: 1.650

4. Activity-based assessment of an engineered hyperthermophilic protein as a capture agent in paper-based diagnostic tests.

Authors: E A Miller; M W Traxlmayr; J Shen; H D Sikes
Journal: Mol Syst Des Eng Date: 2016-06-29

Getting to reproducible antibodies: the rationale for sequenced recombinant characterized reagents.

1. Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.

2. Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility.

3. Construction, characterization and crystal structure of a fluorescent single-chain Fv chimera.

4. Activity-based assessment of an engineered hyperthermophilic protein as a capture agent in paper-based diagnostic tests.

Review 5. Controlling ion channel function with renewable recombinant antibodies.

6. Genetically encoded intrabodies as high-precision tools to visualize and manipulate neuronal function.

7. Epitope mapping of commercial antibodies that detect myocilin.

Review 8. Antibody validation: a view from the mountains.

9. Evaluating Commercially Available Antibodies for Rat α7 Nicotinic Acetylcholine Receptors.

10. Animal- versus in vitro-derived antibodies: avoiding the extremes.